Publication | Closed Access
Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma
31
Citations
0
References
2001
Year
Hematological MalignancyTumor BiologyLymphoid NeoplasiaAngiogenesisHuman AngiogeninMedicineMalignant Blood DisorderImmunologyHematologyPathologyCd30-positive LymphomaAdult T-cell Leukemia-lymphomaImmunotherapyHuman Cd30 LigandCell TransplantationTumor MicroenvironmentCancer Research
No additional data available for this publication yet. Check back later!